Consortium

We have experience in synthesis of biologically active substances and nanoparticles (IOC, University of Helsinki, Farmak); in the development of stimuli-responsive nanocarriers (University of Helsinki, ICTP); in quantum-chemical modelling of the active compounds and nanoparticles (IOC, UIT); in comprehensive biological testing, studies of pharmacokinetics and toxicity profiles (INPA, UFL); in scaling up and validation of proposed technologies (Farmak).

Coordinator

Groups

University of Helsinki university_of_helsinki

IPCB [former ICTP]

IOC

IOCH

UFL

ufl.jpg

UIT

Ibntofail-logo.JPG

INPA

logo-INPA

Farmak

farmak